Eagle Pharmaceuticals, Inc. Business Combination, Contingent Consideration, Liability, Current
Eagle Pharmaceuticals, Inc. had Business Combination, Contingent Consideration, Liability, Current of $0 as of 2018-12-31, per its 10-K filed 2019-02-28.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent · last filed 2019-02-28
- 2018-12-31: Business Combination, Contingent Consideration, Liability, Current $0.00.
- 2018-09-30: Business Combination, Contingent Consideration, Liability, Current $0.00.
- 2018-06-30: Business Combination, Contingent Consideration, Liability, Current $0.00.
- 2018-03-31: Business Combination, Contingent Consideration, Liability, Current $55.00K.
| Period end | Business Combination, Contingent Consideration, Liability, Current |
|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-02-28 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-01 |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-07 |
| 2018-03-31 | $55.00K 10-Q · filed 2018-05-10 |
| 2017-12-31 | $15.05M 10-K · filed 2019-02-28 |
| 2017-09-30 | $55.00K 10-Q · filed 2017-11-08 |
| 2017-06-30 | $1.13M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $1.01M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $1.01M 10-K · filed 2018-02-26 |
| 2016-09-30 | $1.01M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $1.01M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $1.01M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-15 |